In two other pediatric cancers, retinoblastoma and Ewing sarcoma, SYK promotes tumor cell survival and SYK inhibition, using small molecule inhibitors, was identified as a promising treatment option for these diseases [35,36]. Here, SYK is linked to retinoblastoma.